Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage

被引：44

作者：

Seiffge, David J. ^{[1
,2
,3
]}

Kagi, Georg ^{[4
]}

Michel, Patrik ^{[5
]}

Fischer, Urs ^{[6
]}

Bejot, Yannick ^{[7
]}

Wegener, Susanne ^{[8
]}

Zedde, Marialuisa ^{[9
]}

Turc, Guillaume ^{[10
]}

Cordonnier, Charlotte ^{[11
]}

Sandor, Peter S. ^{[12
]}

Rodier, Gilles ^{[13
]}

Zini, Andrea ^{[14
]}

Cappellari, Manuel ^{[15
]}

Schadelin, Sabine ^{[16
]}

Polymeris, Alexandros A. ^{[1
,2
,3
]}

Werring, David ^{[17
,18
]}

Thilemann, Sebastian ^{[1
,2
,3
]}

Maestrini, Ilaria ^{[11
]}

Berge, Eivind ^{[19
,20
]}

Traenka, Christopher ^{[1
,2
,3
]}

Vehoff, Jochen ^{[4
]}

De Marchis, Gian Marco ^{[1
,2
,3
]}

Kapauer, Monika ^{[4
]}

Peters, Nils ^{[1
,2
,3
,21
]}

Sirimarco, Gaia ^{[5
]}

Bonati, Leo H. ^{[1
,2
,3
]}

Arnold, Marcel ^{[6
]}

Lyrer, Philippe A. ^{[1
,2
,3
]}

De Maistre, Emmanuel ^{[22
]}

Luft, Andreas ^{[8
]}

Tsakiris, Dimtrios A. ^{[23
]}

Engelter, Stefan T. ^{[1
,2
,3
,21
]}

机构：

[1] Univ Hosp Basel, Stroke Ctr, Petersgraben 4, CH-4031 Basel, Switzerland

[2] Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland

[3] Univ Hosp, Dept Clin Res, Dept Neurol, Basel, Switzerland

[4] St Gallen Cantonal Hosp, Dept Neurol, St Gallen, Switzerland

[5] Univ Hosp, Dept Neurol, Lausanne, Switzerland

[6] Inselspital Bern, Dept Neurol, Bern, Switzerland

[7] Univ Hosp, Dept Neurol, Dijon Stroke Registry, Dijon, France

[8] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland

[9] New Santa Maria Hosp, Inst Hospitalizat & Sci Care, Neurol Unit, Stroke Unit, Reggio Emilia, Italy

[10] St Anne Hosp, Natl Inst Hlth & Med Res, Dept Neurol, U894, Paris, France

[11] Univ Lille, Lille Univ Hosp Ctr, Natl Inst Hlth & Med Res, U1171,Degenerat & Vasc Cognit Disorders,Dept Neur, Lille, France

[12] Baden Cantonal Hosp, Dept Neurol, Baden, Switzerland

[13] Annecy Genevois Hosp Ctr, Dept Neurol, Epagny Metz Tessy, France

[14] Modena Univ Hosp, SAgostino Estense Hosp, Dept Neurosci, Stroke Unit, Modena, Italy

[15] Integrated Univ Hosp, USD Stroke Unit, DAI Neurosci, Verona, Italy

[16] Univ Hosp Basel, Clin Trial Unit, Basel, Switzerland

[17] UCL, Dept Brain Repair & Rehabil, Ctr Stroke Res, Inst Neurol, London, England

[18] Natl Hosp Neurol & Neurosurg, London, England

[19] Oslo Univ Hosp, Dept Internal Med, Oslo, Norway

[20] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway

[21] Univ Basel, Univ Ctr Med Aging & Rehabil Basel, Felix Platter Hosp, Neurorehabil Unit, Basel, Switzerland

[22] Univ Hosp, Hematol Lab, Dijon, France

[23] Univ Hosp Basel, Diagnost Hematol, Basel, Switzerland

来源：

ANNALS OF NEUROLOGY | 2018年 / 83卷 / 03期

关键词：

HEALTH-CARE PROFESSIONALS; INTRAVENOUS THROMBOLYSIS; ORAL ANTICOAGULANTS; IV THROMBOLYSIS; FACTOR XA; MANAGEMENT; GUIDELINES; COMPLICATIONS; REVERSAL;

D O I：

10.1002/ana.25165

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

ObjectiveInformation about rivaroxaban plasma level (RivLev) may guide treatment decisions in patients with acute ischemic stroke (AIS) and intracerebral hemorrhage (ICH) taking rivaroxaban. MethodsIn a multicenter registry-based study (Novel Oral Anticoagulants in Stroke Patients collaboration; ClinicalTrials.gov: NCT02353585) of patients with stroke while taking rivaroxaban, we compared RivLev in patients with AIS and ICH. We determined how many AIS patients had RivLev100ng/ml, indicating possible eligibility for thrombolysis, and how many ICH patients had RivLev75ng/ml, making them possibly eligible for the use of specific reversal agents. We explored factors associated with RivLev (Spearman correlation, regression models) and studied the sensitivity and specificity of international normalized ratio (INR) thresholds to substitute RivLev using cross tables and receiver operating characteristic curves. ResultsAmong 241 patients (median age=80 years, interquartile range [IQR]=73-84; median time from onset to admission=2 hours, IQR=1-4.5 hours; median RivLev=89ng/ml, IQR=31-194), 190 had AIS and 51 had ICH. RivLev was similar in AIS patients (82ng/ml, IQR=30-202) and ICH patients (102ng/ml, IQR=51-165; p=0.24). Trough RivLev((137ng/ml)) occurred in 126/190 (66.3%) AIS and 34/51 (66.7%) ICH patients. Among AIS patients, 108/190 (56.8%) had RivLev100ng/ml. In ICH patients, 33/51 (64.7%) had RivLev75ng/ml. RivLev was associated with rivaroxaban dosage, and inversely with renal function and time since last intake (each p<0.05). INR1.0 had a specificity of 98.9% and a sensitivity of 25.7% to predict RivLev100ng/ml. INR1.4 had a sensitivity of 59.3% and specificity of 90.1% to predict RivLev75ng/ml. InterpretationRivLev did not differ between patients with AIS and ICH. Half of the patients with AIS under rivaroxaban had a RivLev low enough to consider thrombolysis. In ICH patients, two-thirds had a RivLev high enough to meet the eligibility for the use of a specific reversal agent. INR thresholds perform poorly to inform treatment decisions in individual patients. Ann Neurol 2018;83:451-459

引用

页码：451 / 459

页数：9

共 50 条

[41] Revascularization for Acute Ischemic Stroke Is Safe for Rivaroxaban Users
Kimura, Satoshi
Ogata, Toshiyasu
Fukae, Jiro
Okawa, Masakazu
Higashi, Toshio
Iwaasa, Mitsutoshi
Inoue, Tooru
Tsuboi, Yoshio
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (09): : E427 - E431
[42] Hemorrhage after an acute ischemic stroke
Motto, C
Ciccone, A
Aritzu, E
Boccardi, E
De Grandi, C
Piana, A
Candelise, L
STROKE, 1999, 30 (04) : 761 - 764
[43] Laboratory Factors Predisposing to Risk of Intracerebral Hemorrhage After IV Thrombolysis for Acute Ischemic Stroke
Kamal, Haris
Lail, Navdeep
Kavak, Katelyn
Memon, Aurangzeb
Kandel, Amit
Ching, Marilou
Sawyer, Robert N.
Mowla, Ashkan
STROKE, 2017, 48
[44] Ipsilateral acute ischemic stroke in a patient with concomitant intracerebral hemorrhage successfully treated with mechanical thrombectomy
Sonia Quintas
Javier Villacieros-Álvarez
Eduardo Bárcena-Ruiz
Julio Dotor García-Soto
Jose Vivancos
Neurological Sciences, 2019, 40 : 2659 - 2660
[45] Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke
Mokin, Maxim
Kass-Hout, Tareq
Kass-Hout, Omar
Zivadinov, Robert
Mehta, Bijal
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08): : 852 - 859
[46] Rates and Outcomes of Neurosurgical Evacuation for Thromboytic Related Intracerebral Hemorrhage in Patients with Acute Ischemic Stroke
Norby, Kiersten E.
Adil, Malik M.
Rahman, Haseeb A.
Siddiq, Farhan
Qureshi, Adnan I.
STROKE, 2013, 44 (02)
[47] Outcome of decompressive craniotomy for post-thrombolytic intracerebral hemorrhage in patients with acute ischemic stroke
Rajappa, S.
Sivakumar, S.
CEREBROVASCULAR DISEASES, 2016, 41 : 52 - 52
[48] Factors Contributing to The Incidence of Intracerebral Hemorrhage After Acute Ischemic Stroke Treatment in Older Adults
Avoke, D.
Wilson, S. E.
Patel, M. D.
Burnett, N. M.
Huang, D. Y.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S177 - S178
[49] Do cerebral microbleeds increase the risk of intracerebral hemorrhage after thrombolysis for acute ischemic stroke?
Charidimou, Andreas
Fox, Zoe
Werring, David J.
INTERNATIONAL JOURNAL OF STROKE, 2013, 8 (03) : E1 - E2
[50] Ethnic Disparities in Ischemic Stroke, Intracerebral Hemorrhage, and Subarachnoid Hemorrhage Incidence in The Netherlands
Agyemang, Charles
van Oeffelen, Aloysia A. M.
Norredam, Marie
Kappelle, L. Jaap
Klijn, Catharina J. M.
Bots, Michiel L.
Stronks, Karien
Vaartjes, Ilonca
STROKE, 2014, 45 (11) : 3236 - 3242

← 1 2 3 4 5 →